Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.23 is 25% above its 5-year average of 0.98, around the middle of its 5-year range (0.01–2.41).
As of the fiscal period ended Tuesday, June 30, 2026. 25.31% above its 12-month average of 0.98.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.23.
CURRENT RATIO
1.23
CURRENT RATIO AVG TTM
0.98
CURRENT RATIO AVG 3Y
0.78
CURRENT RATIO AVG 5Y
0.98
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+25.31%
CURRENT VS 3Y AVG
+56.89%
CURRENT VS 5Y AVG
+25.24%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-67.25%
vs the sector median at left
Market Cap
$58.80M
Current Ratio
0.57
TTM Avg
2.81
3Y Avg
4.44
5Y Avg
7.47
Market Cap
$57.09M
Current Ratio
2.37
TTM Avg
7.60
3Y Avg
7.51
5Y Avg
12.19
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | $58.54M | 1.23 | 0.98 | 0.78 | 0.98 |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | 6.71 | 8.38 | 9.61 | 10.03 |
| PDS Biotechnology Corporation (PDSB)vs › | $58.80M | 0.57 | 2.81 | 4.44 | 7.47 |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.90M | 4.25 | 2.40 | 3.43 | 5.08 |
| Boundless Bio, Inc. (BOLD)vs › | $58.21M | 9.48 | 13.86 | 12.45 | 13.81 |
| Talphera, Inc. (TLPH)vs › | $57.61M | 4.29 | 4.53 | 3.35 | 3.13 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.09M | 2.37 | 7.60 | 7.51 | 12.19 |
| Fractyl Health, Inc. (GUTS)vs › | $59.76M | 3.15 | 4.21 | 4.67 | 4.26 |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | 2.43 | 1.42 | 0.94 | 1.84 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.22M | 1.35 | 1.97 | 5.50 | 8.52 |
Current Ratio
1.23
Quick Ratio
1.23
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.23 |
| 2026-03-31 | 1.38 |
| 2025-12-31 | 1.06 |
| 2025-09-30 | 1.08 |
| 2025-06-30 | 0.15 |
| 2025-03-31 | 0.30 |
| 2024-12-31 | 0.72 |
| 2024-09-30 | 0.89 |
| 2024-06-30 | 0.93 |
| 2024-03-31 | 0.54 |
| 2023-12-31 | 0.32 |
| 2023-09-30 | 0.62 |
| 2023-06-30 | 0.96 |
| 2023-03-31 | 1.38 |
| 2022-12-31 | 1.61 |
| 2022-09-30 | 1.33 |
| 2022-06-30 | 1.74 |
| 2022-03-31 | 1.88 |
| 2021-12-31 | 2.41 |
| 2021-09-30 | 0.01 |
| 2021-06-30 | 0.06 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.29 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
